Status:
COMPLETED
Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
FABPulous B.V.
Conditions:
Acute Coronary Syndrome
Angina Pectoris, Unstable
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: Thoracic complaints, possibly due to a cardiac ischemic cause are a diagnostic challenge in general practice. When an underlying ischemic cardiac condition (AMI (acute myocardial infarctio...
Eligibility Criteria
Inclusion
- new-onset chest complaint, considered to be of possible cardiac origin by the general practitioner
- In case of death of identified cause patients are included as well.
Exclusion
- all attention has to be on acute support for the patient
- symptoms are present for more than 24 hours
- oral informed consent is not given during presentation
- written informed consent is refused afterwards
- a traumatic cause is present
- complaints are presented that can be regarded as a recurrence of earlier complaints with clear diagnosis in the past
- death of unidentified cause.
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
303 Patients enrolled
Trial Details
Trial ID
NCT01826994
Start Date
September 1 2013
End Date
December 1 2016
Last Update
April 11 2017
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
ACHG
Leuven, Vlaams Brabant, Belgium, B-3000
2
HOZL
Heerlen, Limburg, Netherlands, 6411TE
3
ZIO
Maastricht, Limburg, Netherlands, 6221 BG
4
Omnes
Sittard, Limburg, Netherlands, 6135 LH